Uneven modulation of the annexin 1 system in osteoblast-like cells by dexamethasone

Biochemical and Biophysical Research Communications

Volumn 354, Issue 2, 2007, Pages 414-419

  Giner, Rosa M ^a,b   Mancini, Lucia ^b   Kamal, Ahmad M ^b   Perretti, Mauro ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Annexin A1; Dexamethasone; FPR; FPRL 1; Interleukin 6; mRNA; Saos 2

Indexed keywords

CYTOKINE; DEXAMETHASONE; FORMYLPEPTIDE RECEPTOR; FORMYLPEPTIDE RECEPTOR LIKE 1; INTERLEUKIN 1; INTERLEUKIN 6; LIPOCORTIN 1; MESSENGER RNA;

ARTICLE; BONE; CELL SURFACE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; INCUBATION TIME; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANNEXIN A1; CELL LINE, TUMOR; DEXAMETHASONE; GLUCOCORTICOIDS; HUMANS; OSTEOBLASTS; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN;

EID: 33846639268     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.224     Document Type: Article

References (26)

1. Gerke V., and Moss S.E. Annexins: from structure to function. Physiol. Rev. 82 (2002) 331-371
2. Mohiti J., Caswell A.M., and Walker J.H. Calcium-induced relocation of annexins IV and V in the human osteosarcoma cell line MG-63. Mol. Membr. Biol. 12 (1995) 321-329
3. Kirsch T., Harrison G., Golub E.E., and Nah H.D. The roles of annexins and types II and X collagen in matrix vesicle-mediated mineralization of growth plate cartilage. J. Biol. Chem. 275 (2000) 35577-35583
4. White A.H., Watson R.E., Newman B., Freemont A.J., and Wallis G.A. Annexin VIII is differentially expressed by chondrocytes in the mammalian growth plate during endochondral ossification and in osteoarthritic cartilage. J. Bone Miner. Res. 17 (2002) 1851-1858
5. Chepenik K.P., Shipman-Appasamy P., Ahn N., and Goldowitz D. Developmental regulation of various annexins in the embryonic palate of the mouse: dexamethasone affects expression of annexin-1. J. Craniofac. Genet. Dev. Biol. 15 (1995) 171-181
6. Menaa C., Devlin R.D., Reddy S.V., Gazitt Y., Choi S.J., and Roodman G.D. Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures. J. Clin. Invest. 103 (1999) 1605-1613
7. Takahashi S., Reddy S.V., Chirgwin J.M., Devlin R., Haipek C., Anderson J., and Roodman G.D. Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption. J. Biol. Chem. 269 (1994) 28696-28701
8. Perretti M., Croxtall J.D., Wheller S.K., Goulding N.J., Hannon R., and Flower R.J. Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration. Nat. Med. 22 (1996) 1259-1262
9. Perretti M., Chiang N., La M., Fierro I.M., Marullo S., Getting S.J., Solito E., and Serhan C.N. Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A(4) receptor. Nat. Med. 8 (2002) 1296-1302
10. Le Y., Murphy P.M., and Wang J.M. Formyl-peptide receptors revisited. Trends Immunol. 23 (2002) 541-548
11. Reid I.R. Steroid-induced osteoporosis. Osteoporos Int. 7 (1997) S213-S216
12. Weinstein R.S., Jilka R.L., Parfitt A.M., and Manolagas S.C. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J. Clin. Invest. 102 (1998) 274-282
13. Hofbauer L.C., Gori F., Riggs B.L., Lacey D.L., Dunstan C.R., Spelsberg T.C., and Khosla S. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140 (1999) 4382-4389
14. Sawmynaden P., and Perretti M. Glucocorticoid upregulation of the annexin-A1 receptor in leukocytes. Biochem. Biophys. Res. Commun. 349 (2006) 1351-1355
15. Oliani S.M., Paul-Clark M.J., Christian H.C., Flower R.J., and Perretti M. Neutrophil interaction with inflamed postcapillary venule endothelium alters annexin 1 expression. Am. J. Pathol. 158 (2001) 603-615
16. Croxtall J.D., and Flower R.J. Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line. Proc. Natl. Acad. Sci. USA 89 (1992) 3571-3575
17. Wang J.L., Gray R.M., Haudek K.C., and Patterson R.J. Nucleocytoplasmic lectins. Biochim. Biophys. Acta 1673 (2004) 75-93
18. Croxtall J.D., van Hal P.T., Choudhury Q., Gilroy D.W., and Flower R.J. Different glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells. Br. J. Pharmacol. 135 (2002) 511-519
19. Solito E., Mulla A., Morris J.F., Christian H.C., Flower R.J., and Buckingham J.C. Dexamethasone induces rapid serine-phosphorylation and membrane translocation of annexin 1 in a human folliculostellate cell line via a novel nongenomic mechanism involving the glucocorticoid receptor, protein kinase C, phosphatidylinositol 3-kinase, and mitogen-activated protein kinase. Endocrinology 144 (2003) 1164-1174
20. Solito E., Christian H.C., Festa M., Mulla A., Tierney T., Flower R.J., and Buckingham J.C. Post-translational modification plays an essential role in the translocation of annexin A1 from the cytoplasm to the cell surface. FASEB J. 20 (2006) 1498-1500
21. Thivierge M., Parent J.L., Stankova J., and Rola-Pleszczynski M. Modulation of formyl peptide receptor expression by IL-10 in human monocytes and neutrophils. J. Immunol. 162 (1999) 3590-3595
22. Elagoz A., Henderson D., Babu P.S., Salter S., Grahames C., Bowers L., Roy M.O., Laplante P., Grazzini E., Ahmad S., and Lembo P.M. A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. Br. J. Pharmacol. 141 (2004) 37-46
23. Ehrchen J., Steinmuller L., Barczyk K., Tenbrock K., Nacken W., Eisenacher M., Nordhues U., Sorg C., Sunderkotter C., and Roth J. Glucocorticoids induce differentiation of a specifically activated, anti-inflammatory subtype of human monocytes. Blood (2006)
24. Rodan G.A. Introduction to bone biology. Bone 13 Suppl. 1 (1992) S3-S6
25. Baumann H., and Gauldie J. The acute phase response. Immunol. Today 15 (1994) 74-80
26. Xing Z., Gauldie J., Cox G., Baumann H., Jordana M., Lei X.F., and Achong M.K. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101 (1998) 311-320